Multi-target-directed ligands for treating Alzheimer's disease: Butyrylcholinesterase inhibitors displaying antioxidant and neuroprotective activities

European Journal of Medicinal Chemistry
Damijan KnezStanislav Gobec

Abstract

The limited clinical efficacy of current symptomatic treatment and minute effect on progression of Alzheimer's disease has shifted the research focus from single targets towards multi-target-directed ligands. Here, a potent selective inhibitor of human butyrylcholinesterase was used as the starting point to develop a new series of multifunctional ligands. A focused library of derivatives was designed and synthesised that showed both butyrylcholinesterase inhibition and good antioxidant activity as determined by the DPPH assay. The crystal structure of compound 11 in complex with butyrylcholinesterase revealed the molecular basis for its low nanomolar inhibition of butyrylcholinesterase (Ki = 1.09 ± 0.12 nM). In addition, compounds 8 and 11 show metal-chelating properties, and reduce the redox activity of chelated Cu2+ ions in a Cu-ascorbate redox system. Compounds 8 and 11 decrease intracellular levels of reactive oxygen species, and are not substrates of the active efflux transport system, as determined in Caco2 cells. Compound 11 also protects neuroblastoma SH-SY5Y cells from toxic Aβ1-42 species. These data indicate that compounds 8 and 11 are promising multifunctional lead ligands for treatment of Alzheimer's disease.

Citations

Jan 1, 2020·Biomolecules·Gabriela Dumitrita StanciuDaniela Carmen Ababei
Dec 15, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Mariagrazia RulloLeonardo Pisani
Nov 12, 2019·Bioorganic & Medicinal Chemistry Letters·Alexander WilliamsChang-Guo Zhan
Nov 2, 2018·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Oksana LockridgeFlorian Nachon
Jul 3, 2021·Foods·Zully J Suárez MontenegroElena Ibáñez
Jun 20, 2020·ACS Chemical Neuroscience·Ashley J MasonGal Bitan
Jun 23, 2020·ACS Pharmacology & Translational Science·Shashikala BhutePallab Bhattacharya
Oct 24, 2020·Journal of Medicinal Chemistry·Giuseppe Felice MangiatordiMarialessandra Contino
Aug 23, 2021·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Chang LiuRui Shen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.